Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duane A Mitchell

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Cancer Immunology, Immunotherapy : CII|August 29, 2013
A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine modelShicheng Yang, Gary E Archer, Catherine E Flores, et al.
Future Oncology (London, England)|July 11, 2013
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumorsVidyalakshmi Chandramohan, Duane A Mitchell, Laura A Johnson, et al.
Human Gene Therapy|May 13, 2008
Selective modification of antigen-specific T cells by RNA electroporationDuane A Mitchell, Isaac Karikari, Xiuyu Cui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2020
Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in GlioblastomaKristen A Batich, Duane A Mitchell, Patrick Healy, et al.
Seminars in Immunology|June 10, 2008
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant gliomaJohn H Sampson, Gary E Archer, Duane A Mitchell, et al.
Genome Medicine|August 19, 2024
Identification of tumor rejection antigens and the immunologic landscape of medulloblastomaChanglin Yang, Vrunda Trivedi, Kyle Dyson, et al.
Neuro-Oncology|October 24, 2007
Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastomaDuane A Mitchell, Weihua Xie, Robert Schmittling, et al.
Expert Review of Clinical Pharmacology|August 10, 2013
An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastomaPatrick C Gedeon, Bryan D Choi, Tiffany R Hodges, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2015
Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastomaElias J Sayour, Pat McLendon, Roger McLendon, et al.
Frontiers in Immunology|August 23, 2021
Optimizing T Cell-Based Therapy for GlioblastomaAida Karachi, Farhad Dastmalchi, Saina Nazarian, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Cancer Immunology, Immunotherapy : CII|August 29, 2013
A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine modelShicheng Yang, Gary E Archer, Catherine E Flores, et al.
Future Oncology (London, England)|July 11, 2013
Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumorsVidyalakshmi Chandramohan, Duane A Mitchell, Laura A Johnson, et al.
Human Gene Therapy|May 13, 2008
Selective modification of antigen-specific T cells by RNA electroporationDuane A Mitchell, Isaac Karikari, Xiuyu Cui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2020
Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in GlioblastomaKristen A Batich, Duane A Mitchell, Patrick Healy, et al.
Seminars in Immunology|June 10, 2008
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant gliomaJohn H Sampson, Gary E Archer, Duane A Mitchell, et al.
Genome Medicine|August 19, 2024
Identification of tumor rejection antigens and the immunologic landscape of medulloblastomaChanglin Yang, Vrunda Trivedi, Kyle Dyson, et al.
Neuro-Oncology|October 24, 2007
Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastomaDuane A Mitchell, Weihua Xie, Robert Schmittling, et al.
Expert Review of Clinical Pharmacology|August 10, 2013
An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastomaPatrick C Gedeon, Bryan D Choi, Tiffany R Hodges, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2015
Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastomaElias J Sayour, Pat McLendon, Roger McLendon, et al.
Frontiers in Immunology|August 23, 2021
Optimizing T Cell-Based Therapy for GlioblastomaAida Karachi, Farhad Dastmalchi, Saina Nazarian, et al.
Pageof 13